Literature DB >> 29443148

The value proposition of case reports: Novelty, pedagogy, anecdotal aggregation, humanity.

.   

Abstract

Year:  2014        PMID： 29443148      PMCID： PMC5759976          DOI： 10.1212/CPJ.0000000000000090

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  8 in total

1.  Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.

Authors:  Annette Langer-Gould; Scott W Atlas; Ari J Green; Andrew W Bollen; Daniel Pelletier
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

2.  Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.

Authors:  B K Kleinschmidt-DeMasters; Kenneth L Tyler
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

3.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Authors:  Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

4.  Postmarketing adverse drug reactions: A duty to report?

Authors:  Eran Klein; Dennis Bourdette
Journal:  Neurol Clin Pract       Date:  2013-08

5.  The case report redefined with JBJS Case Connector.

Authors:  Marc F Swiontkowski; Vernon T Tolo
Journal:  J Bone Joint Surg Am       Date:  2013-01-16       Impact factor: 5.284

6.  The case for case reports.

Authors:  Shamik Bhattacharrya; Julie Miller; Allan H Ropper
Journal:  Ann Neurol       Date:  2014-09-19       Impact factor: 10.422

7.  Postmarketing adverse drug reactions: A duty to report?

Authors:  Khichar Shubhakaran; Rekha Jakur Khichar
Journal:  Neurol Clin Pract       Date:  2014-02

8.  Are randomized, blind clinical trials enough to guide individualized decisions for patients with neurologic diseases?

Authors:  Yazan J Alderazi; Roberto Bomprezzi
Journal:  Neurol Clin Pract       Date:  2014-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.